EVEREST MED.LTD DL-0001
Research EVEREST MED.LTD DL-0001 (6HN) on Bullrun: market cap EUR 934.56M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6HN
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 934.56M
- Financial periodFY2025
- RevenueEUR 1.71B
- Revenue growth141.5%
- Net income-EUR 297.77M
- Free cash flow-EUR 440.90M
- Gross margin69.3%
Valuation Snapshot
latest market cap is EUR 934.56M.
About EVEREST MED.LTD DL-0001
Everest Medicines Limited, a biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets. It pipeline includes Nefecon, an oral formulation of budesonide for the treatment of immunoglobulin nephropathy (IgAN);
Frequently asked questions
What is EVEREST MED.LTD DL-0001's market cap?
EVEREST MED.LTD DL-0001's market capitalization is EUR 934.56M.
What does EVEREST MED.LTD DL-0001 do?
Everest Medicines Limited, a biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.